Is antimicrobial resistance also subject to globalization?

Clinical Microbiology and Infection

Volumn 8, Issue SUPPL. 3, 2002, Pages 1-8

  Schito, Gian Carlo ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMINOPENICILLIN; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINCOMYCIN; MACROLIDE; METICILLIN; OFLOXACIN; OXACILLIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; UNINDEXED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COMMUNICABLE DISEASE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG USE; ENZYME SYNTHESIS; GEOGRAPHIC PATHOLOGY; HAEMOPHILUS INFLUENZAE; HOSPITAL HYGIENE; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION CONTROL; ITALY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MOLECULAR CLONING; MORAXELLA CATARRHALIS; NONHUMAN; PENICILLIN RESISTANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; STANDARD; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORAXELLA CATARRHALIS; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 0037219001     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.8.s.3.1.x     Document Type: Article

References (30)

1. Schito GC, Debbia EA, Marchese A. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project. J Antimicrob Chemother 2000; 46(Suppl. T1): 3-9.
2. Schito GC, Pesce A, Marchese A. The role of macrolides in Streptococcus pyogenes pharyngitis. J Antimicrob Chemother 1997; 39: 562-5.
3. Stingemore N, Francis GR, Toohey M, McGechie DB. The emergence of erythromycin resistance in Streptococcus pyogenes. in Fremantle, Western Australia Medical J Aust 1989; 150: 626-7; 630-1.
4. Seppala H, Nissinen A, Yu Q, Huovinen P. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 1993; 32: 885-91.
5. Maruyama S, Yoshioka H, Fujita K, Takimoto M, Satake Y. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am J Dis Child 1979; 133: 1143-5.
6. Fujii R. Present state of antibiotic consumption in Japan. Saishiu-Igaku 1977; 32: 1439-45.
7. Fujita K, Murono K, Yoshikawa M, Murai T. Decline of erythromycin resistance of group A streptococci in Japan. Pediatr Infect Dis J 1994; 13: 1075-8.
8. Hsueh PR, Chen HM, Huang AH, Wu JJ. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother 1995; 39: 2239-42.
9. Seppala H, Klaukka T, Lehtonen R, Nenonen E, Huovinen P. Outpatient use of erythromycin: link to increased erythromycin resistance in group A streptococci. Clin Infect Dis 1995; 21: 1378-85.
10. Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997; 337: 441-6.
11. Zackrisson G, Lind L, Roos K, Larsson P. Erythromycin-resistant beta-hemolytic streptococci group A in Goteborg, Sweden. Scand J Infect Dis 1988; 20: 419-20.
12. Bingen E, Fitoussi F, Doit C et al. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother 2000: 44;1453-7.
13. Orden B, Perez-Trallero E, Montes M, Martinez R. Erythromycin reistance of Streptococcus pyogenes in: Madrid. Pediatr Infect Dis 1998: 17: 470-3.
14. Baquero F. Gram-positive resistance challenge for the development of new antibiotics. J Antimicrob Chemother, 1997; 39(Suppl. A): 1-6.
15. Fluit AC, Wielders CL, Verhoef J, Schmitz FJ. Epidemiology and susceptibility of 3,051 Staphylococcus aureus isolates from 25 University hospitals participating in the European SENTRY study. J Clin Microbiol 2001; 39: 3727-32.
16. Fleisch F, Zbinden R, Vanoli C, Ruef C. Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland. Clin Infect Dis 2001; 32: 581-6.
17. Salmenlinna S, Vuopio-Varkila J. Recognition of two groups of methicillin-resistant Staphylococcus aureus strains based on epidemiology, antimicrobial susceptibility, hypervariable-region type, and ribotype in Finland. J Clin Microbiol 2001; 39: 2243-7.
18. Simor AE, Ofner-Agostini M, Bryce E et al. The evolution of methicillin-resistant Staphylococcus aureus in Canadian hospitals: 5 years of national surveillance. Can Med Assoc J 2001; 165: 21-6.
19. Deplano A, Witte W, van Leeuwen WJ, Brun Y, Struelens MJ. Clonal dissemination of epidemic methicillin-resistant Staphylococcus aureus in Belgium and neighboring countries. Clin Microbiol Infect 2000; 6: 239-45.
20. Sa-Leao R, Sanches IS, Couto I, Alves CR, de Lencastre H. Low prevalence of methicillin-resistant strains among Staphylococcus aureus colonizing young and healthy members of the community in Portugal. Microb Drug Resist 2001; 7: 237-45.
21. Wang JT, Chen YC, Yang TL, Chang SC. Molecular epidemiology and antimicrobial susceptibility of methicillin-resistant Staphylococcus aureus in Taiwan. Diagn Microbiol Infect Dis 2002: 42; 199-203.
22. Verma S, Joshi S, Chitnis V, Hemwani N, Chitnis D. Growing problem of methicillin resistant staphylococci - Indian scenario. Indian J Med Sci 2000; 54: 535-40.
23. Crisostomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lencastre H. The evolution of methicillin resistance in Staphylococcus aureus. Similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci USA 2001; 98: 9865-70.
24. Roman RS, Smith J, Walker M et al. Rapid geographic spread of a methicillin-resistant Staphylococcus aureus strain. Clin Infect Dis 1997; 25: 698-705.
25. Rampling A, Wiseman S, Davis L et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2001; 49: 109-16.
26. Marchese A, Mannelli S, Tonoli E, Gorlero F, Toni M, Schito GC. Prevalence of antimicrobial resistance in Streptococcus pneumoniae circulating in Italy: results of the Italian Epidemiological Observatory Survey (1997-1999). Microb Drug Resist 2001; 7: 277-87.
27. Marchese A, Ramirez M, Schito GC, Tomasz A. Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996. J Clin Microbiol 1998; 36: 2944-9.
28. Esposito S. Outpatient parenteral treatment of bacterial infections: the Italian model as an international trend? J Antimicrob Chemother 2000; 45: 724-7.
29. National Committee for Clinical Laboratory Standards. M100-S12 January 2002: NCCLS. Performance standards for antimicrobial susceptibility testing, 12th Informational Supplement. Wayne PA: NCCLS.
30. Varaldo PE, Debbia EA, Nicoletti G et al Nationwide survey in Italy of treatment of Streptococcus pyogenes pharyngitis in children: influence of macrolide resistance on clinical and microbiological outcomes. Artemis-Italy Study Group. Clin Infect Dis 1999; 29: 869-73.